and targeted therapies
for the treatment of
Pascal Biosciences is dedicated to improving the lives of patients suffering from life-threatening diseases such as glioblastoma and other intractable cancers. We are developing novel cannabinoid-based small molecules and targeted antibodies, focusing on cancers for which there are no adequate therapies.
Pascal Biosciences Announces Continuing Discussions with SŌRSE Technology and Testing of Cannabinoids for COVID-19 Treatment
May 27, 2020Read More
Pascal Biosciences Announces Private Placement and Potential Transaction with SŌRSE Technology for Cannabinoid Research Programs
March 10, 2020Read More